Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.01B |
| 2 |
Humana
HUM
|
+$659M |
| 3 |
Apple
AAPL
|
+$579M |
| 4 |
Microsoft
MSFT
|
+$515M |
| 5 |
Home Depot
HD
|
+$508M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$744M |
| 2 |
McDonald's
MCD
|
+$604M |
| 3 |
Cigna
CI
|
+$500M |
| 4 |
Digital Realty Trust
DLR
|
+$424M |
| 5 |
Amazon
AMZN
|
+$407M |
Sector Composition
| 1 | Technology | 19.72% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 10.08% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4526
Valvoline
VVV
$4.92B
| $174K | ﹤0.01% |
5,408
-527,971
| -99% | -$17M |
|
|
LUNA
4527
DELISTED
Luna Innovations Incorporated
LUNA
| $174K | ﹤0.01% |
29,735
-18,275
| -38% | -$107K |
|
|
VINC
4528
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $174K | ﹤0.01% |
8,441
-24,585
| -74% | -$506K |
|
4529
CBIZ
CBZ
$2.9B
| $172K | ﹤0.01% |
3,322
-7,925
| -70% | -$411K |
|
|
SPRB
4530
Spruce Biosciences
SPRB
$4.72M
| $170K | ﹤0.01% |
75,030
+3,753
| +5% | +$8.48K |
|
4531
Sutro Biopharma
STRO
$75.2M
| $169K | ﹤0.01% |
48,589
+20,261
| +72% | +$70.3K |
|
4532
Northfield Bancorp
NFBK
$487M
| $169K | ﹤0.01% |
17,833
-125,762
| -88% | -$1.19M |
|
4533
Simplify Intermediate Term Treasury Futures Strategy ETF
TYA
$90.4M
| $168K | ﹤0.01% |
+13,200
| New | +$168K |
|
4534
Blend Labs
BLND
$1.03B
| $168K | ﹤0.01% |
122,411
+93,084
| +317% | +$128K |
|
4535
TrueCar
TRUE
$205M
| $168K | ﹤0.01% |
80,942
-66,136
| -45% | -$137K |
|
4536
MeiraGTx Holdings
MGTX
$608M
| $167K | ﹤0.01% |
33,983
-5,449
| -14% | -$26.8K |
|
|
DRD
4537
DRDGold
DRD
$2.21B
| $167K | ﹤0.01% |
20,065
+14,853
| +285% | +$123K |
|
4538
InfuSystem Holdings
INFU
$204M
| $166K | ﹤0.01% |
17,271
+15,031
| +671% | +$145K |
|
4539
Inogen
INGN
$234M
| $166K | ﹤0.01% |
31,880
-418,525
| -93% | -$2.18M |
|
4540
Xtrackers S&P 500 ESG ETF
SNPE
$2.13B
| $165K | ﹤0.01% |
4,208
-6,442
| -60% | -$252K |
|
4541
Arteris
AIP
$421M
| $165K | ﹤0.01% |
25,272
-48,476
| -66% | -$316K |
|
4542
Beam Global
BEEM
$48.5M
| $164K | ﹤0.01% |
22,242
+21,206
| +2,047% | +$157K |
|
4543
Richardson Electronics
RELL
$145M
| $164K | ﹤0.01% |
14,968
-12,122
| -45% | -$132K |
|
4544
Celldex Therapeutics
CLDX
$1.63B
| $163K | ﹤0.01% |
5,925
-84,825
| -93% | -$2.33M |
|
4545
iShares US Industrials ETF
IYJ
$1.68B
| $162K | ﹤0.01% |
1,604
-22,508
| -93% | -$2.27M |
|
4546
RAVE Restaurant Group
RAVE
$51.2M
| $160K | ﹤0.01% |
67,682
+38,913
| +135% | +$92.2K |
|
|
HEPS
4547
D-Market Electronic Services & Trading
HEPS
$955M
| $160K | ﹤0.01% |
120,488
-32,599
| -21% | -$43.4K |
|
4548
Astria Therapeutics
ATXS
$398M
| $160K | ﹤0.01% |
21,449
+21,014
| +4,831% | +$157K |
|
|
NRT
4549
North European Oil Royalty Trust
NRT
$47.1M
| $160K | ﹤0.01% |
13,095
+3,021
| +30% | +$36.9K |
|
|
PVLA
4550
Palvella Therapeutics
PVLA
$644M
| $160K | ﹤0.01% |
6,695
-18,278
| -73% | -$436K |
|